Scale Bio, BioLegend TotalSeq Phenocyte Single-Cell Protein Profiling

Scale Biosciences and Revvity's BioLegend business have launched TotalSeq Phenocyte single-cell protein profiling, a product for identifying and characterizing rare cell subtypes. It is based on Scale Bio's Quantum Barcoding technology and BioLegend's TotalSeq-A antibody conjugates and the result of a collaboration the companies announced earlier this year. It aims to help with biomarker discovery and the identification of rare cells in a heterogeneous population, targeting immunology and oncology research.